Credit: Photo courtesy of The Scripps Research Institute.
Scientists at The Scripps Research Institute have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.